Global Atovaquone Market Growth 2025-2031

October 2025 | 80 pages | ID: GD7D1A230C8EN
LP Information

Abstracts

The global Atovaquone market size is predicted to grow from US$ 215 million in 2025 to US$ 312 million in 2031; it is expected to grow at a CAGR of 6.4% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP). This medication helps to stop infection symptoms such as fever, cough, tiredness, and shortness of breath.

United States market for Atovaquone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Atovaquone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Atovaquone is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Atovaquone players cover GSK, Lupin, Apotex, Amneal Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Atovaquone Industry Forecast? looks at past sales and reviews total world Atovaquone sales in 2024, providing a comprehensive analysis by region and market sector of projected Atovaquone sales for 2025 through 2031. With Atovaquone sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Atovaquone industry.

This Insight Report provides a comprehensive analysis of the global Atovaquone landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Atovaquone portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Atovaquone market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Atovaquone and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Atovaquone.

This report presents a comprehensive overview, market shares, and growth opportunities of Atovaquone market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• 250mg
• 500mg

Segmentation by Application:

• Hospital
• Drug Store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• GSK
• Lupin
• Apotex
• Amneal Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Atovaquone market?
What factors are driving Atovaquone market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Atovaquone market opportunities vary by end market size?
How does Atovaquone break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Atovaquone Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Atovaquone by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Atovaquone by Country/Region, 2020, 2024 & 2031
2.2 Atovaquone Segment by Type
  2.2.1 250mg
  2.2.2 500mg
2.3 Atovaquone Sales by Type
  2.3.1 Global Atovaquone Sales Market Share by Type (2020-2025)
  2.3.2 Global Atovaquone Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Atovaquone Sale Price by Type (2020-2025)
2.4 Atovaquone Segment by Application
  2.4.1 Hospital
  2.4.2 Drug Store
2.5 Atovaquone Sales by Application
  2.5.1 Global Atovaquone Sale Market Share by Application (2020-2025)
  2.5.2 Global Atovaquone Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Atovaquone Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Atovaquone Breakdown Data by Company
  3.1.1 Global Atovaquone Annual Sales by Company (2020-2025)
  3.1.2 Global Atovaquone Sales Market Share by Company (2020-2025)
3.2 Global Atovaquone Annual Revenue by Company (2020-2025)
  3.2.1 Global Atovaquone Revenue by Company (2020-2025)
  3.2.2 Global Atovaquone Revenue Market Share by Company (2020-2025)
3.3 Global Atovaquone Sale Price by Company
3.4 Key Manufacturers Atovaquone Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Atovaquone Product Location Distribution
  3.4.2 Players Atovaquone Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR ATOVAQUONE BY GEOGRAPHIC REGION

4.1 World Historic Atovaquone Market Size by Geographic Region (2020-2025)
  4.1.1 Global Atovaquone Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Atovaquone Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Atovaquone Market Size by Country/Region (2020-2025)
  4.2.1 Global Atovaquone Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Atovaquone Annual Revenue by Country/Region (2020-2025)
4.3 Americas Atovaquone Sales Growth
4.4 APAC Atovaquone Sales Growth
4.5 Europe Atovaquone Sales Growth
4.6 Middle East & Africa Atovaquone Sales Growth

5 AMERICAS

5.1 Americas Atovaquone Sales by Country
  5.1.1 Americas Atovaquone Sales by Country (2020-2025)
  5.1.2 Americas Atovaquone Revenue by Country (2020-2025)
5.2 Americas Atovaquone Sales by Type (2020-2025)
5.3 Americas Atovaquone Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Atovaquone Sales by Region
  6.1.1 APAC Atovaquone Sales by Region (2020-2025)
  6.1.2 APAC Atovaquone Revenue by Region (2020-2025)
6.2 APAC Atovaquone Sales by Type (2020-2025)
6.3 APAC Atovaquone Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Atovaquone by Country
  7.1.1 Europe Atovaquone Sales by Country (2020-2025)
  7.1.2 Europe Atovaquone Revenue by Country (2020-2025)
7.2 Europe Atovaquone Sales by Type (2020-2025)
7.3 Europe Atovaquone Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Atovaquone by Country
  8.1.1 Middle East & Africa Atovaquone Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Atovaquone Revenue by Country (2020-2025)
8.2 Middle East & Africa Atovaquone Sales by Type (2020-2025)
8.3 Middle East & Africa Atovaquone Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Atovaquone
10.3 Manufacturing Process Analysis of Atovaquone
10.4 Industry Chain Structure of Atovaquone

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Atovaquone Distributors
11.3 Atovaquone Customer

12 WORLD FORECAST REVIEW FOR ATOVAQUONE BY GEOGRAPHIC REGION

12.1 Global Atovaquone Market Size Forecast by Region
  12.1.1 Global Atovaquone Forecast by Region (2026-2031)
  12.1.2 Global Atovaquone Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Atovaquone Forecast by Type (2026-2031)
12.7 Global Atovaquone Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 GSK
  13.1.1 GSK Company Information
  13.1.2 GSK Atovaquone Product Portfolios and Specifications
  13.1.3 GSK Atovaquone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 GSK Main Business Overview
  13.1.5 GSK Latest Developments
13.2 Lupin
  13.2.1 Lupin Company Information
  13.2.2 Lupin Atovaquone Product Portfolios and Specifications
  13.2.3 Lupin Atovaquone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Lupin Main Business Overview
  13.2.5 Lupin Latest Developments
13.3 Apotex
  13.3.1 Apotex Company Information
  13.3.2 Apotex Atovaquone Product Portfolios and Specifications
  13.3.3 Apotex Atovaquone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Apotex Main Business Overview
  13.3.5 Apotex Latest Developments
13.4 Amneal Pharmaceuticals
  13.4.1 Amneal Pharmaceuticals Company Information
  13.4.2 Amneal Pharmaceuticals Atovaquone Product Portfolios and Specifications
  13.4.3 Amneal Pharmaceuticals Atovaquone Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Amneal Pharmaceuticals Main Business Overview
  13.4.5 Amneal Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Atovaquone Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Atovaquone Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 250mg
Table 4. Major Players of 500mg
Table 5. Global Atovaquone Sales by Type (2020-2025) & (K Units)
Table 6. Global Atovaquone Sales Market Share by Type (2020-2025)
Table 7. Global Atovaquone Revenue by Type (2020-2025) & ($ million)
Table 8. Global Atovaquone Revenue Market Share by Type (2020-2025)
Table 9. Global Atovaquone Sale Price by Type (2020-2025) & (USD/Unit)
Table 10. Global Atovaquone Sale by Application (2020-2025) & (K Units)
Table 11. Global Atovaquone Sale Market Share by Application (2020-2025)
Table 12. Global Atovaquone Revenue by Application (2020-2025) & ($ million)
Table 13. Global Atovaquone Revenue Market Share by Application (2020-2025)
Table 14. Global Atovaquone Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Atovaquone Sales by Company (2020-2025) & (K Units)
Table 16. Global Atovaquone Sales Market Share by Company (2020-2025)
Table 17. Global Atovaquone Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Atovaquone Revenue Market Share by Company (2020-2025)
Table 19. Global Atovaquone Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Atovaquone Producing Area Distribution and Sales Area
Table 21. Players Atovaquone Products Offered
Table 22. Atovaquone Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Atovaquone Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Atovaquone Sales Market Share Geographic Region (2020-2025)
Table 27. Global Atovaquone Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Atovaquone Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Atovaquone Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Atovaquone Sales Market Share by Country/Region (2020-2025)
Table 31. Global Atovaquone Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Atovaquone Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Atovaquone Sales by Country (2020-2025) & (K Units)
Table 34. Americas Atovaquone Sales Market Share by Country (2020-2025)
Table 35. Americas Atovaquone Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Atovaquone Sales by Type (2020-2025) & (K Units)
Table 37. Americas Atovaquone Sales by Application (2020-2025) & (K Units)
Table 38. APAC Atovaquone Sales by Region (2020-2025) & (K Units)
Table 39. APAC Atovaquone Sales Market Share by Region (2020-2025)
Table 40. APAC Atovaquone Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Atovaquone Sales by Type (2020-2025) & (K Units)
Table 42. APAC Atovaquone Sales by Application (2020-2025) & (K Units)
Table 43. Europe Atovaquone Sales by Country (2020-2025) & (K Units)
Table 44. Europe Atovaquone Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Atovaquone Sales by Type (2020-2025) & (K Units)
Table 46. Europe Atovaquone Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Atovaquone Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Atovaquone Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Atovaquone Sales by Type (2020-2025) & (K Units)
Table 50. Middle East & Africa Atovaquone Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Atovaquone
Table 52. Key Market Challenges & Risks of Atovaquone
Table 53. Key Industry Trends of Atovaquone
Table 54. Atovaquone Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Atovaquone Distributors List
Table 57. Atovaquone Customer List
Table 58. Global Atovaquone Sales Forecast by Region (2026-2031) & (K Units)
Table 59. Global Atovaquone Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Atovaquone Sales Forecast by Country (2026-2031) & (K Units)
Table 61. Americas Atovaquone Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Atovaquone Sales Forecast by Region (2026-2031) & (K Units)
Table 63. APAC Atovaquone Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Atovaquone Sales Forecast by Country (2026-2031) & (K Units)
Table 65. Europe Atovaquone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Atovaquone Sales Forecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Atovaquone Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Atovaquone Sales Forecast by Type (2026-2031) & (K Units)
Table 69. Global Atovaquone Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Atovaquone Sales Forecast by Application (2026-2031) & (K Units)
Table 71. Global Atovaquone Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. GSK Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors
Table 73. GSK Atovaquone Product Portfolios and Specifications
Table 74. GSK Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. GSK Main Business
Table 76. GSK Latest Developments
Table 77. Lupin Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors
Table 78. Lupin Atovaquone Product Portfolios and Specifications
Table 79. Lupin Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Lupin Main Business
Table 81. Lupin Latest Developments
Table 82. Apotex Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors
Table 83. Apotex Atovaquone Product Portfolios and Specifications
Table 84. Apotex Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Apotex Main Business
Table 86. Apotex Latest Developments
Table 87. Amneal Pharmaceuticals Basic Information, Atovaquone Manufacturing Base, Sales Area and Its Competitors
Table 88. Amneal Pharmaceuticals Atovaquone Product Portfolios and Specifications
Table 89. Amneal Pharmaceuticals Atovaquone Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Amneal Pharmaceuticals Main Business
Table 91. Amneal Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Atovaquone
Figure 2. Atovaquone Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Atovaquone Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Atovaquone Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Atovaquone Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Atovaquone Sales Market Share by Country/Region (2024)
Figure 10. Atovaquone Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 250mg
Figure 12. Product Picture of 500mg
Figure 13. Global Atovaquone Sales Market Share by Type in 2025
Figure 14. Global Atovaquone Revenue Market Share by Type (2020-2025)
Figure 15. Atovaquone Consumed in Hospital
Figure 16. Global Atovaquone Market: Hospital (2020-2025) & (K Units)
Figure 17. Atovaquone Consumed in Drug Store
Figure 18. Global Atovaquone Market: Drug Store (2020-2025) & (K Units)
Figure 19. Global Atovaquone Sale Market Share by Application (2024)
Figure 20. Global Atovaquone Revenue Market Share by Application in 2025
Figure 21. Atovaquone Sales by Company in 2025 (K Units)
Figure 22. Global Atovaquone Sales Market Share by Company in 2025
Figure 23. Atovaquone Revenue by Company in 2025 ($ millions)
Figure 24. Global Atovaquone Revenue Market Share by Company in 2025
Figure 25. Global Atovaquone Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Atovaquone Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Atovaquone Sales 2020-2025 (K Units)
Figure 28. Americas Atovaquone Revenue 2020-2025 ($ millions)
Figure 29. APAC Atovaquone Sales 2020-2025 (K Units)
Figure 30. APAC Atovaquone Revenue 2020-2025 ($ millions)
Figure 31. Europe Atovaquone Sales 2020-2025 (K Units)
Figure 32. Europe Atovaquone Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Atovaquone Sales 2020-2025 (K Units)
Figure 34. Middle East & Africa Atovaquone Revenue 2020-2025 ($ millions)
Figure 35. Americas Atovaquone Sales Market Share by Country in 2025
Figure 36. Americas Atovaquone Revenue Market Share by Country (2020-2025)
Figure 37. Americas Atovaquone Sales Market Share by Type (2020-2025)
Figure 38. Americas Atovaquone Sales Market Share by Application (2020-2025)
Figure 39. United States Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Atovaquone Sales Market Share by Region in 2025
Figure 44. APAC Atovaquone Revenue Market Share by Region (2020-2025)
Figure 45. APAC Atovaquone Sales Market Share by Type (2020-2025)
Figure 46. APAC Atovaquone Sales Market Share by Application (2020-2025)
Figure 47. China Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 51. India Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Atovaquone Sales Market Share by Country in 2025
Figure 55. Europe Atovaquone Revenue Market Share by Country (2020-2025)
Figure 56. Europe Atovaquone Sales Market Share by Type (2020-2025)
Figure 57. Europe Atovaquone Sales Market Share by Application (2020-2025)
Figure 58. Germany Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 59. France Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Atovaquone Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Atovaquone Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Atovaquone Sales Market Share by Application (2020-2025)
Figure 66. Egypt Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Atovaquone Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Atovaquone in 2025
Figure 72. Manufacturing Process Analysis of Atovaquone
Figure 73. Industry Chain Structure of Atovaquone
Figure 74. Channels of Distribution
Figure 75. Global Atovaquone Sales Market Forecast by Region (2026-2031)
Figure 76. Global Atovaquone Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Atovaquone Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Atovaquone Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Atovaquone Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Atovaquone Revenue Market Share Forecast by Application (2026-2031)